False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma

Br J Radiol. 2002 Jun;75(894):548-51. doi: 10.1259/bjr.75.894.750548.

Abstract

We present the case of a patient who showed increased accumulation of (123)I-metaiodobenzylguanidine (MIBG) in hepatocellular carcinoma, leading to a false presumptive diagnosis of intrahepatic neuroendocrine tumour. The increase in uptake was not seen on images obtained 4 h after tracer injection but was evident on those taken after 24 h, suggesting slower washout from the liver tumour than from non-tumoural liver parenchyma. Our observations indicate that a non-neuroendocrine malignant tumour may exhibit high accumulation of MIBG associated with prolonged retention.

Publication types

  • Case Reports

MeSH terms

  • 3-Iodobenzylguanidine / pharmacokinetics*
  • Aged
  • Carcinoma, Hepatocellular / diagnostic imaging
  • Carcinoma, Hepatocellular / metabolism*
  • Diagnosis, Differential
  • False Positive Reactions
  • Humans
  • Hypertension / diagnostic imaging
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / metabolism*
  • Male
  • Neuroendocrine Tumors / diagnostic imaging
  • Neuroendocrine Tumors / metabolism
  • Radionuclide Imaging
  • Radiopharmaceuticals / pharmacokinetics*

Substances

  • Radiopharmaceuticals
  • 3-Iodobenzylguanidine